CN Patent

CN101252931A — 用于治疗癌症的4-苯胺基-3-喹啉甲腈

Assigned to Wyeth LLC · Expires 2008-08-27 · 18y expired

What this patent protects

本发明涉及一种使用式(I)化合物或其药学上可接受的盐来预防、治疗和/或抑制癌症的方法。本发明还涉及含有式(I)化合物的药物组合物。

USPTO Abstract

本发明涉及一种使用式(I)化合物或其药学上可接受的盐来预防、治疗和/或抑制癌症的方法。本发明还涉及含有式(I)化合物的药物组合物。

Drugs covered by this patent

bosutinib-monohydrate (BOSUTINIB MONOHYDRATE)

Patent Metadata

Patent number: CN101252931A
Jurisdiction: CN
Classification: —
Expires: 2008-08-27
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.